INNOVENT BIO (01801) Annual Reports
信達生物 ・ Listed on the Main Board of the Hong Kong Stock Exchange, classified under Healthcare - Pharmaceuticals & Biotechnology (Pharmaceuticals). This page collects every annual report, interim report and results announcement filed by the company. All PDFs come directly from HKEXnews.
INNOVENT BIO filings by year
About INNOVENT BIO annual reports
Where can I download INNOVENT BIO (01801) annual reports?
Every year in the table above links straight to the PDF on HKEXnews, the Hong Kong Stock Exchange's official filing system. Both English and Chinese editions are available. 8 annual reports are indexed, covering 2018 to 2025.
Do Hong Kong listed companies publish quarterly reports?
No. Main Board issuers are only required to publish an interim report (half-year) and an annual report. Quarterly financial reporting is not mandatory, so Hong Kong filings arrive twice a year rather than four times. This page holds 7 interim reports for INNOVENT BIO.
What is the difference between an annual report and a results announcement?
A results announcement (final or interim) is the condensed financial summary a company releases shortly after the period ends — usually a few dozen pages. The annual report follows months later and contains the audited financial statements, the directors' report and corporate governance disclosures. Read the announcement for the numbers first, the annual report for the full picture.
Browse all Hong Kong listed companies, or read this page in Chinese.